Patents by Inventor Robert John Steffan

Robert John Steffan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo [1,2-A] Pyridine Compounds
    Publication number: 20110112135
    Abstract: This invention relates generally to imidazo[1,2-a]pyridine-based modulators of Liver X receptors (LXRs) having formula (I) and related methods: wherein R2 is C6-C10 aryl or heteroaryl including 5-10 atoms, each of which is: (i) substituted with 1 R7, and (ii) optionally substituted with from 1-5 Re; and R1, R3, R4, R5, R6, R7, and Re are defined herein.
    Type: Application
    Filed: December 19, 2008
    Publication date: May 12, 2011
    Inventors: Robert Ray Singhaus, JR., Ronald Charles Bernotas, Jay Edward Wrobel, Robert John Steffan, Edward Martin Matelan
  • [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones
    Patent number: 7598286
    Abstract: This invention provides anti-inflammatory agents of formula I, having the structure wherein A and R1-R10 are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.
    Type: Grant
    Filed: October 27, 2005
    Date of Patent: October 6, 2009
    Assignee: Wyeth
    Inventors: Robert John Steffan, Edward Martin Matelan
  • Phenanthridine carbonyl phenols
    Patent number: 7585871
    Abstract: The present invention relates generally to phenanthridine carbonyl compositions such as substituted phenanthridine carbonyl phenols of Formula 1: wherein R1 to R15 are as defined in the specification, or pharmaceutically acceptable salts thereof; and methods of using them.
    Type: Grant
    Filed: August 30, 2005
    Date of Patent: September 8, 2009
    Assignee: Wyeth
    Inventors: Robert John Steffan, William Jay Moore, Eugene J. Trybulski, Albert John Molinari
  • Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine &bgr;-3 adrenergic receptor agonists
    Patent number: 6506901
    Abstract: This invention provides compounds of Formula I having the structure wherein A, B, Z, R and R1 are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia (typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination; and are particularly useful in the treatment or inhibition of type II diabetes.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: January 14, 2003
    Assignee: Wyeth
    Inventors: Robert John Steffan, Mark Anthony Ashwell, Jeffrey Claude Pelletier, William Ronald Solvibile, Edward Martin Matelan